People · Operator

Marc Pelletier

Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology

1
Companies
2
Filings
$14.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Aeromics, Inc.BiotechnologySeries A$14.1M$340.3M2014
Operator network

Marc Pelletier at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Christine F. Antalik · 1 companies · 1 sharedChristine F. Anta…Frederick F. Jones · 1 companies · 1 sharedFrederick F. JonesGeorge F. Farr · 1 companies · 1 sharedGeorge F. FarrJeff F. Draime · 1 companies · 1 sharedJeff F. DraimeJeffrey F. Draime · 1 companies · 1 sharedJeffrey F. DraimeJohn F. Foster · 1 companies · 1 sharedJohn F. FosterMarc F. Pelletier · 1 companies · 1 sharedMarc F. PelletierMark F. Day · 1 companies · 1 sharedMark F. DayPaul F. McGuirk · 1 companies · 1 sharedPaul F. McGuirkPaul F. Schlather · 1 companies · 1 sharedPaul F. SchlatherPeter F. Longo · 1 companies · 1 sharedPeter F. LongoThomas F. Zindrick · 1 companies · 1 sharedThomas F. ZindrickWalter Boron · 1 companies · 1 sharedWalter BoronWalter F. Boron · 1 companies · 1 sharedWalter F. BoronAeromics, Inc. · $14.1M raisedAeromics, Inc.Marc PelletierMP
Marc Pelletier Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Marc Pelletier on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Walter Boron11
Frederick F. Jones11
Paul F. McGuirk11
Peter F. Longo11
Walter F. Boron11
George F. Farr11
Marc F. Pelletier11
John F. Foster11
Jeffrey F. Draime11
Mark F. Day11
Thomas F. Zindrick11
Christine F. Antalik11
Paul F. Schlather11
Jeff F. Draime11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.